BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31269849)

  • 1. The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy.
    Zou P; Li H; Cai J; Li C; Chen Z; Li X
    Ren Fail; 2019 Nov; 41(1):623-628. PubMed ID: 31269849
    [No Abstract]   [Full Text] [Related]  

  • 2. A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy.
    Zou PM; Li H; Cai JF; Chen ZJ; Li C; Xu P; Li MX; Chen LM; Li XM; Li XW
    Chin Med Sci J; 2018 Jun; 33(2):91-99. PubMed ID: 29976278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent Anticoagulation Does Not Reduce Venous Thromboembolism in High-Risk Patients.
    Tan TL; Foltz C; Huang R; Chen AF; Higuera C; Siqueira M; Hansen EN; Sing DC; Parvizi J
    J Bone Joint Surg Am; 2019 Apr; 101(7):589-599. PubMed ID: 30946192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trials.
    Chapelle C; Rosencher N; Jacques Zufferey P; Mismetti P; Cucherat M; Laporte S;
    Arthroscopy; 2014 Aug; 30(8):987-96. PubMed ID: 24813323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
    Galambosi PJ; Ulander VM; Kaaja RJ
    Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins can benefit patients with primary membranous nephropathy on venous thromboembolism.
    Zou P; Li H; Cai J; Chen Z; Li C; Li X
    Ren Fail; 2021 Dec; 43(1):302-306. PubMed ID: 33583321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.
    Camporese G; Bernardi E; Prandoni P; Noventa F; Verlato F; Simioni P; Ntita K; Salmistraro G; Frangos C; Rossi F; Cordova R; Franz F; Zucchetta P; Kontothanassis D; Andreozzi GM;
    Ann Intern Med; 2008 Jul; 149(2):73-82. PubMed ID: 18626046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some Points for the KDIGO 2021 Guideline for Prophylactic Anticoagulation in Membranous Nephropathy: Is It Clear Enough for Us to Follow?
    Li X; Xie X; Zhao Y; Wang G; Shao H; Zhang X
    Nephron; 2023; 147(3-4):193-198. PubMed ID: 35901785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low molecular weight heparin combined with aspirin to prevent perioperative venous thromboembolism in patients with splenic rupture and lower extremity fracture].
    Tang Y; Xu Y; Zhang X; Song J; Wang K; Yang P
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2022 Nov; 36(11):1381-1387. PubMed ID: 36382456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry.
    Jameson SS; Charman SC; Gregg PJ; Reed MR; van der Meulen JH
    J Bone Joint Surg Br; 2011 Nov; 93(11):1465-70. PubMed ID: 22058295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The timing of venous thromboembolic events after spine surgery: a single-center experience with 6869 consecutive patients.
    Cloney MB; Hopkins B; Dhillon ES; Dahdaleh NS
    J Neurosurg Spine; 2018 Jan; 28(1):88-95. PubMed ID: 29125431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: Results from a randomized controlled trial of aspirin versus low molecular weight heparin.
    Haac BE; Van Besien R; O'Hara NN; Slobogean GP; Manson TT; O'Toole RV; Johal H; Berger PZ; Reahl GB; Marinos D; Degani Y; Mascarenhas D; Connelly D; Scalea TM; Stein DM
    J Trauma Acute Care Surg; 2018 Apr; 84(4):564-574. PubMed ID: 29251700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins, aspirin and risk of thromboembolic events in ovarian cancer patients.
    Shai A; Rennert HS; Rennert G; Sagi S; Leviov M; Lavie O
    Gynecol Oncol; 2014 May; 133(2):304-8. PubMed ID: 24631448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
    Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
    J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data.
    Jameson SS; Baker PN; Charman SC; Deehan DJ; Reed MR; Gregg PJ; Van der Meulen JH
    J Bone Joint Surg Br; 2012 Jul; 94(7):914-8. PubMed ID: 22733945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thrombosis from air travel: the LONFLIT3 study--prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial.
    Cesarone MR; Belcaro G; Nicolaides AN; Incandela L; De S; Geroulakos G; Lennox A; Myers KA; Moia M; Ippolito E; Winford M
    Angiology; 2002; 53(1):1-6. PubMed ID: 11863301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
    Asopa V; Cobain W; Martin D; Keene G; Bauze A
    ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients.
    Patel AR; Crist MK; Nemitz J; Mayerson JL
    J Surg Oncol; 2010 Sep; 102(3):276-81. PubMed ID: 20740587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.